Insmed Inc. buy The Goldman Sachs Group, Inc.
Start price
13.08.25
/
50%
€104.00
Target price
13.08.26
€121.61
Performance (%)
28.85%
Price
03.10.25
€129.00
Summary
This prediction is currently active. The prediction currently has a performance of 28.85%. This prediction currently runs until 13.08.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 12.174% | 12.174% |
| iShares Core DAX® | 2.709% | 3.467% |
| iShares Nasdaq 100 | 0.867% | 5.198% |
| iShares Nikkei 225® | 3.135% | 9.423% |
| iShares S&P 500 | 0.886% | 3.586% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $114.00 to $142.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat